Back to List View Graph View

Cyclin-dependent kinase 1 (CDK1)

Cyclin dependent kinase 1 (CDK1) is a core serine/threonine protein kinase that plays a central role in cell-cycle control, particularly the transition into and progression through mitosis.

Where the papers sit

8 papers from the last 6 months study Cyclin-dependent kinase 1 (CDK1) directly · updated from PubMed 15 Nov 2026

Study type 0 clinical trials · 2 human data · 6 preclinical

Themes one subject

Those 8 are all about one subject.

  • CDK1 Biology and Therapeutics

    CDK1 links cell-cycle control to cancer progression, treatment response, and tissue injury. Recurrent mechanisms include Cyclin B1 signaling, Wee1 suppression, mitotic catastrophe, apoptosis, and Drp1-dependent mitochondrial fission. Therapeutic work spans RNAi prodrugs, natural compounds, and selective CDK1 inhibitors designed through molecular modeling. The field remains exploratory, with evidence ranging from cancer-cell studies to diabetic nephropathy and pan-cancer analyses.

    8 papers

Papers

The 8 papers from the last 6 months that study Cyclin-dependent kinase 1 (CDK1) directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.

By theme

CDK1 Biology and Therapeutics (8)
  1. Engineered dual RNAi prodrug for combined suppression of survival and cell cycle pathways in triple negative breast cancer treatment. Chemical communications (Cambridge, England) · 16 Oct 2026 PMID 42885730
  2. TET2 aggravates podocyte mitotic catastrophe and renal injury in diabetic nephropathy via m5C-dependent downregulation of Wee1 and activation of CDK1-cyclinB1 signaling. Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 5 Sept 2026 PMID 42700265
  3. β-Elemene Triggers Drp1-Dependent Mitochondrial Fission Through CDK1/Cyclin B1 Signaling in Cervical Cancer Cells. Journal of biochemical and molecular toxicology · 27 Jul 2026 PMID 42506883
  4. Trichodermin exhibits potent anti-glioblastoma activity by inducing cell cycle arrest and apoptosis, suppressing invasion, and enhancing temozolomide efficacy. Journal of enzyme inhibition and medicinal chemistry · 20 Jul 2026 PMID 42474259
  5. Investigating the mechanisms of malignant progression in colorectal cancer using weighted gene co-expression network analysis and machine learning. Journal of molecular histology · 18 Jul 2026 PMID 42470494
  6. Molecular modeling of highly selective CDK1 Inhibitors based on pyrazolo-pyrimidines using 3D-QSAR, docking, and molecular dynamics simulations. PloS one · 22 Jun 2026 PMID 42329991
  7. Utilizing Molecular Dynamics and Mechanistic Pharmacokinetic Studies in the Design of Selective CDK2 Inhibitors. Journal of medicinal chemistry · 22 Jun 2026 PMID 42328801
  8. Multi-omics and pan-cancer analysis revealed common molecular signatures to disclose multitargeted anticancer agents through network pharmacology approach. PloS one · 1 Jun 2026 PMID 42224282

By study type

Human data, design not indexed (2)
  1. Molecular modeling of highly selective CDK1 Inhibitors based on pyrazolo-pyrimidines using 3D-QSAR, docking, and molecular dynamics simulations. PloS one · 22 Jun 2026 PMID 42329991
  2. Multi-omics and pan-cancer analysis revealed common molecular signatures to disclose multitargeted anticancer agents through network pharmacology approach. PloS one · 1 Jun 2026 PMID 42224282
Preclinical: animal, cell and lab studies (6)
  1. Engineered dual RNAi prodrug for combined suppression of survival and cell cycle pathways in triple negative breast cancer treatment. Chemical communications (Cambridge, England) · 16 Oct 2026 PMID 42885730
  2. TET2 aggravates podocyte mitotic catastrophe and renal injury in diabetic nephropathy via m5C-dependent downregulation of Wee1 and activation of CDK1-cyclinB1 signaling. Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 5 Sept 2026 PMID 42700265
  3. β-Elemene Triggers Drp1-Dependent Mitochondrial Fission Through CDK1/Cyclin B1 Signaling in Cervical Cancer Cells. Journal of biochemical and molecular toxicology · 27 Jul 2026 PMID 42506883
  4. Trichodermin exhibits potent anti-glioblastoma activity by inducing cell cycle arrest and apoptosis, suppressing invasion, and enhancing temozolomide efficacy. Journal of enzyme inhibition and medicinal chemistry · 20 Jul 2026 PMID 42474259
  5. Investigating the mechanisms of malignant progression in colorectal cancer using weighted gene co-expression network analysis and machine learning. Journal of molecular histology · 18 Jul 2026 PMID 42470494
  6. Utilizing Molecular Dynamics and Mechanistic Pharmacokinetic Studies in the Design of Selective CDK2 Inhibitors. Journal of medicinal chemistry · 22 Jun 2026 PMID 42328801